Hearing Loss / 08.01.2024
5 Ways Hearing Aids Will Improve Your Life
One step at a time, hearing aids are becoming an almost mandatory part of the superior hearing experience....
One step at a time, hearing aids are becoming an almost mandatory part of the superior hearing experience....
Dr. Zhang[/caption]
Jianzhi "George" Zhang
In today's fast-paced medical scene, have you heard about the tech-savvy guardians of health information? Say hello to informatics nurses. These professionals stand at the crossroads where nursing, computer know-how, and data crunching meet. They're the folks who make sure patient info is spot-on, easy to get to, and as safe as a treasure in a vault. But it's not just about keeping records; they're all about making the day-to-day in hospitals and clinics run smoother. With their expertise, every piece of vital data is organized and used the right way to help the medical team do their thing efficiently.
Dr. Lu Qi[/caption]
Lu Qi, MD, PhD, FAHA
Interim Chair, Department of Epidemiolog
HCA Regents Distinguished Chair and Professor
Tulane University School of Public Health and Tropical Medicine
Director, Tulane University Obesity Research Center
Director, Tulane Personalized Health Institute
New Orleans, LA 70112
MedicalResearch.com: What is the background for this study?
Response: Adding salt to foods is a behavior reflecting long-term preference to salty diets. High sodium intake is a major risk factor for chronic kidney disease.
In our previous studies, we have found that adding salt to foods at the table is related to various disorders including cardiovascular diseases, diabetes, and mortality.
Dr. Christian Carbe[/caption]
Christian Carbe, PhD
Department of Medical Educatio
Geisinger Commonwealth School of Medicine
Scranton, PA 18509
MedicalResearch.com: What is the background for this study?
Response: Transgender patients often experience pronounced healthcare disparities compared to their cisgender counterparts. Disparities in the treatment of transgender patients resulting from deficiencies in cultural competency perpetuate poor health outcomes, such as suicide, substance misuse, depression, harassment, and victimization.
Individuals within the transgender community often face systemic barriers within the medical field, including a lack of comprehensive access to health insurance, discrimination from providers, and incompetent provider training in transgender-specific health needs.
This report evaluated the changes in knowledge, attitudes, and beliefs of the psychosocial and medical needs of the transgender community among first-year undergraduate medical students that attended the Northeastern Pennsylvania Trans Health Conference. Our broader goal is to develop and refine longitudinal interventions to improve skills and sensitivity of future physicians to provide compassionate and competent gender diverse and transgender healthcare.
It is essential to recognize the diverse manifestations of addiction that have infiltrated our society....
Amy Kennalley[/caption]
Amy Kennalley, MBS
First Year Medical Student
Department of Medical Education
Geisinger Commonwealth School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Opioid use disorder (OUD) is a major public health crisis in the United States. Despite the availability of effective treatments, including the medication-assisted treatment (MAT) with methadone, many individuals with OUD do not receive the care they need. Over the COVID-19 pandemic, there were several policy changes related to take-home doses of methadone, which may have impacted access to this lifesaving medication.
The Drug Enforcement Administration's (DEA)'s Automated Reports and Consolidated Ordering System (ARCOS) is a database that tracks the distribution of controlled substances, including methadone distributed to opioid treatment programs (OTPs). This data can be used to assess trends in methadone distribution over time. Additionally, the Medicaid State Drug Utilization Data (SDUD) database provides comprehensive information on methadone prescribing to Medicaid patients.
By analyzing data from both ARCOS and SDUD, we aimed to provide a comprehensive picture of methadone distribution for OUD treatment in the United States. These findings1 are important because drug overdose deaths, primarily involving opioids, increased substantially (49%) from 2019 (70,980) to 2021 (~106,000).2
Dr. Klompas[/caption]
Michael Klompas MD, MPH, FIDSA, FSHEA
Hospital Epidemiologist
Brigham and Women’s Hospital
Professor of Medicine and Population Medicine
Harvard Medical School and
Harvard Pilgrim Health Care Institute
MedicalResearch.com: What is the background for this study? Can teeth be safely brush in patients who are comatose, intubated or have NG tubes?
Response: Pneumonia is thought to occur when secretions from the mouth get into the lungs. Since there are many microbes in the mouth, there’s a risk that secretions from the mouth that get into the lungs will lead to pneumonia. Toothbrushing may lower this risk by decreasing the quantity of microbes in the mouth.
It is indeed safe and appropriate to brush the teeth of someone who is comatose, intubated, or who has an NG tube. Indeed, our study found that the benefits of toothbrushing were clearest for patients receiving mechanical ventilation.
Dr. Angélica Cifuentes Kottkamp[/caption]
Angélica Cifuentes Kottkamp, MD
Assistant Professor of Medicine
NYU Grossman School of Medicine
Associate Program Director
Infectious Diseases & Immunology Fellowship
Associate Director for Research & Diversity
NYU Langone Vaccine Center & VTEU
Attending Physician
H+H Bellevue Virology Clinic
Division of Infectious Diseases & Immunology
NYU Grossman School of Medicine
MedicalResearch.com: What is the background for this study? How does the JYNNEOS vaccine differ from the smallpox vaccine?
Response: JYNNEOS vaccine is a smallpox vaccine that was repurposed for Mpox given the similarities between the two viruses (smallpox and mpox). The vaccine (JYNNEOS) had been studied in people without HIV therefore there was a gap in knowledge in how this vaccine, especially the small dose (intradermal dose), would work in patients with HIV.
These patients resulted to be the most affected by the mpox outbreak suffering the worse outcomes of the disease with the highest death rates.
Dr. Brousseau[/caption]
David Brousseau, MD, MS
Chair of Pediatrics
Nemours Children’s Health, Delaware and the
Sidney Kimmel Medical College at Thomas Jefferson University
MedicalResearch.com: What is the background for this study?
Response: Sickle cell disease (SCD) is an inherited red blood cell disorder – the most common genetic disorder in the United States, affecting about 100,000 Americans (1 of every 365 Black births and 1 of every 16,3000 Hispanic-American births) (source: CDC).
Pain is its most common symptom. Patients may experience acute or chronic pain or both. Acute episodes of pain, or pain crises, can vary in duration and severity. Many are treated at home; however when the pain is excruciating and cannot be treated at home, they lead to Emergency Department (ED) visits and even hospitalization.
Reducing pain through prompt administration of pain medication in the ED is a core principle of national guidelines for SCD care. However, little data exists on how pain scores and changes in pain scores in the ED are associated with the patient’s disposition and the odds of a return visit.
Dr. Kang[/caption]
Jessie Kang, MD, FRCPC
Assistant professor
Department of Diagnostic Radiology
Faculty of Medicine
Dalhousie University
MedicalResearch.com: What is the background for this study?
Dr. DiPiro[/caption]
Joseph T. DiPiro, Pharm.D
Associate Vice President, Faculty Affairs
Virginia Commonwealth University
Dr. DiPiro is an editor for Pharmacotherapy: A Pathophysiologic Approach
MedicalResearch.com: What is the background for this study?
Response: The ASHP/ASHP Foundation Pharmacy Forecast Report is constructed from a survey of health-system pharmacy leaders who were asked to rate the likelihood of events, scenarios, and trends occurring in the next five years. The purpose is for health-system pharmacists and pharmacy leaders to inform their strategic planning efforts. The Pharmacy Forecast is not intended to predict future events. Rather, the report is intended to be a provocative stimulant for the thinking, discussion, and planning that must take place in every health system. Leaders must be informed of potential developments to help position their organizations to care for patients, enhance population health, and improve medication outcomes.
Prof. Nathan Berger[/caption]
Nathan A. Berger, M.D.
Distinguished University Professor
Prof. Rong Xu[/caption]
Rong Xu, PhD
Professor, Biomedical Informatics
Director, Center for Artificial Intelligence in Drug Discovery
Case Western Reserve University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: 75% of the US Population has overweight or obesity and 15% has Type 2 Diabetes.
Both overweight/obesity and diabetes promote increased incidence and worse prognosis of colorectal cancer.
The new GLP1RA drug class are rapidly becoming the most effective treatment for both diabetes and overweight/obesity.
By controlling diabetes and overweight/obesity, we hypothesized that the GLP1RAs might be effective at reducing incidence of colorectal cancer.
Dr. Davaasambuu[/caption]
Dr Ganmaa Davaasambuu MD PhD
Associate Professor
Harvard T.H. Chan School of Public Health
MedicalResearch.com: What is the background for this study?
Response: The crucial role of vitamin D in facilitating calcium absorption from the diet and promoting calcium deposition in bones (known as 'mineralization') has been a long-established understanding. Furthermore, some observational studies have reported an association between low vitamin D levels and a heightened risk of bone fractures in children. This raised the possibility that vitamin D supplements could potentially play a role in decreasing fracture risk in children with initially low baseline levels. However, clinical trials assessing the causal link between low vitamin D status and reduced fracture risk were necessary, and such trials had not been conducted before.
Dr. Anchan[/caption]
Raymond M. Anchan, MD, Ph.D.
Director, Stem Cell Biology and Regenerative Medicine Research Laboratory
Assistant Professor, Harvard Medical School
Obstetrics/Gynecology
Center for Infertility and Reproductive Surgery
Brigham and Women's Hospital
MedicalResearch.com: What is the background for this study?
Response: As a reproductive endocrinologist, I have the privilege of caring for patients who unfortunately experience premature ovarian insufficiency- Some of these patients are as young as 17 yo. Additionally, a significant number of patients over the years have been reproductive age women who have breast cancer and ovarian failure from chemotherapy. These patients have been my inspiration to try to find a treatment for them. Since my earlier days as a neurobiologist and stem cell scientist, it was a natural course for me to seek cell-based therapies that are patient specific using autologous iPSCs.
Dr. Callaghan[/caption]
Bridget Callaghan Ph.D.
Assistant Professor of Psychology
UCLA
Dr. Callahan studies interactions between mental and physical health across development.
MedicalResearch.com: What is the background for this study?
Response: A growing body of evidence links the gut microbiome to brain and immune functioning, and changes to that community of microorganisms is likely among the ways that hardship affects children’s socioemotional development.
Limited evidence in humans has demonstrated the adversities experienced prenatally and during early life influence the composition of the gut microbiome, but no studies had examined whether stress experienced in a mother's own childhood could influence the microbiome of the next generation of children.
Kazi Albab Hussain[/caption]
Kazi Albab Hussain
Graduate Student (PhD)
Specialization: Water Resources
Advisor: Professor Yusong Li, PhD
Associate Dean for Faculty and Inclusion
MedicalResearch.com: What is the background for this study?
Response: Microplastics have been detected in various food items and beverages, including table salt, bottled water, fish, and mussels. The extensive use of plastic-based products in food preparation, storage, and handling has raised concerns about the direct release of microplastics. Interestingly, we often discuss microplastics but overlook nanoplastics in the conversation. Due to their smaller size, nanoplastics are harder to be detected.
In our study, we wanted to see the release of both microplastics and nanoplastics, as nanoplastics may be even more toxic than microplastics.
Unfortunately, infants and toddlers are particularly vulnerable to the potential health impacts of micro- and nanoplastics. Studies have shown significant ingestion of these particles from polypropylene feeding bottles and silicone-rubber baby teats. We aimed to investigate the release of of micro- and nanoplastics, estimated their exposure for infants and toddlers, and evaluated their cytotoxicity to human embryonic kidney cells.
Dr. Chi-yuan Hsu[/caption]
Chi-yuan Hsu, MD, MSc (he/him/his)
Professor and Division Chief
Robert W. Schrier Distinguished Professor
Division of Nephrology
University of California, San Francisco
MedicalResearch.com: What is the background for this study?
Response: Acute kidney injury (AKI) had previously been considered a reversible short-term medical problem among hospitalized patients without long-term sequalae in that there is recovery of kidney function back to baseline should the patient survive the hospitalization.
Then about 15 years ago, the concept began to shift as research by us and others showed that for patients with severe AKI (e.g. AKI severe enough to require acute dialysis in the hospital), there was more rapid subsequent loss of renal function.
Now based largely on additional observational studies in humans (and animal models), many nephrologists and opinion leaders think that even mild to moderate cases of AKI have long-term sequelae. We are concerned that the paradigm has swung too much in the opposite direction and we questioned the results of many published studies which did not fully account for differences in background kidney function among those who did and did not experience AKI.
Dr. Kelleher[/caption]
Cassandra Kelleher, MD
Surgical Director, Fetal Care Program
Surgical Director, Neonatal Intensive Care Unit
Physician Investigator (Cl)
Surgery, Mass General Research Institute
Associate Professor of Surgery
Harvard Medical School
MedicalResearch.com: What is the background for this study?
Response: Physicians practicing in academic hospitals have unique responsibilities. They are not only expected to treat patients, but also to conduct research to improve treatments for future patients, and to train future physicians.
Diverse healthcare teams have better patient outcomes and lower healthcare costs. Women physicians, for example, are more likely to practice patient-centered care, and through their teaching and research work at academic medical centers, they help to disseminate and normalize novel approaches to practicing medicine. For these reasons, gender diversity in academic medicine is important for the quality of healthcare in the future.
Dr. Newman-Toker[/caption]
David E. Newman-Toker, MD PhD (he/him)
Professor of Neurology, Ophthalmology, & Otolaryngology
David Robinson Professor of Vestibular Neurology
Director, Division of Neuro-Visual & Vestibular Disorders
Director, Armstrong Institute Center for Diagnostic Excellence
Johns Hopkins Medicine
MedicalResearch.com: What is the background for this study?
Response: Diagnostic errors are believed to be a major public health issue, but valid, quantitative estimates of harm are lacking. In 2015, the National Academy of Medicine stated in their report Improving Diagnosis in Healthcare that improving diagnosis was a “moral, professional, and public health imperative” yet also noted that “the available research [is] not adequate to extrapolate a specific estimate or range of the incidence of diagnostic errors in clinical practice today.” We sought a scientifically robust answer to the question of how many patients in the US suffer serious harms as a result of medical misdiagnosis.
MedicalResearch.com: What is the background for this study?
Response: I became interested in dog's sense of smell several years ago while doing therapy dog demonstrations at the California Science Center in Los Angeles during a special traveling exhibit "Dogs! A Science Tail." (Now at the Orlando Science Center). I did a lot of research on this topic and taught children about it through the Los Angeles Public Library using my Great Pyrenees therapy dogs. Then, COVID broke out and I expanded my research into any work being done to possibly utilize scent dogs for screening and testing for COVID. I found only a few such studies. However, I fortuitously met Heather Junqueira of BioScent, Inc. (in Florida) online and she was beginning to successfully teach her beagles to detect COVID-related odors. She agreed to co-author a peer-reviewed review paper with me. That led to our first paper -
Dickey, T, Junqueira, H. Toward the use of medical scent dogs for COVID-19 screening. J Osteopath Med 2021;1(2): 141-148. https://doi.org/10.1515/jom-2020-0222
When the COVID pandemic began to wane at the beginning of this year, I felt that it would be the perfect time to do this comprehensive follow-up review to see how far COVID scent dog research had progressed. To our amazement, research efforts had increased by almost tenfold and involved over 400 scientists using over 31,000 samples (including sniffings) from over 30 countries and that 29 peer reviewed papers had been published.
Heather’s inspiration for doing scent dog work came when her father contracted cancer and she wanted to find better diagnostics. She has since been successful in detecting non-small cell lung cancer with her trained beagles as well as COVID.
Dr. Guttman-Yassky[/caption]
Emma Guttman-Yassky, M.D., PhD,
Lead investigator of this study
Waldman Professor and
System Chair
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai, NY
MedicalResearch.com: What is the background for this study?
Response: The idea to test how spacing out treatment or even stopping it affects treatment responses once patients are well controlled. Lebrikizumab it is a potent biologic agent with a relatively long-lasting effect.
The relationship between psychiatry and psychotherapy is not smooth sailing. Click here to learn more about the two....
Dr. Prior[/caption]
Jerilynn C Prior MD FRCPC (on behalf of all authors
Professor of Endocrinology / Department of Medicine
University of British Columbia
Centre for Menstrual Cycle and Ovulation Research www.cemcor.ca
BC Women’s Health Research Institute
Vancouver BC Canada
MedicalResearch.com: What is the background for this study?
Response: Night sweats and hot flushes/flashes (together called vasomotor symptoms, VMS) disturb women who are still menstruating (in perimenopause) are at least as much or more than menopausal women (without flow for a year or more)1. However, although studies have investigated various treatments for perimenopausal hot flushes/flashes, none have proven effective in these women who are also likely to be having heavy flow, breast tenderness, and premenstrual symptoms related to high and variable estrogen levels. These include randomized controlled trials (RCT) of the birth control pill2, and gel estrogen in women using a progestin-releasing IUD3.
Neither showed that therapy was more effective than placebo; both studied too few participants to provide a clear answer.
Meanwhile, major medical organization guidelines recommend menopausal hormone therapy (MHT, usually of estrogen with a progestin) for any women younger than 60 years old who are bothered by night sweats and hot flushes 4-6. However, there are no scientific RCT studies showing MHT is effective for perimenopausal night sweats and hot flushes. Giving more estrogen to someone whose own estrogen levels are often high, also did not make clinical sense.
We previously performed an RCT showing that oral micronized progesterone (progesterone) was effective for menopausal hot flushes and also improved sleep7. Given that progesterone levels in perimenopausal women are declining, we considered that perimenopausal progesterone therapy for night sweats needed testing.
There seems to be a clear association of certain gut species with atherosclerosis, but more studies are needed to determine...